Miravant Medical TechnologiesOver The Counter Market:MRVT
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Miravant Medical Technologies | 40.0 | 0.0x | --- |
Poniard Pharmaceuticals Inc | 150.0 | 0.0x | --- |
Anthera Pharmaceuticals Inc | 30.0 | 0.0x | --- |
Oncovista Innovative Therapies Inc | 2.4K | 0.0x | --- |
Pathfinder Cell Therapy Inc | 670.0 | 0.0x | --- |
FluoroPharma Medical Inc | 3.4K | 0.0x | --- |
Company Information
Miravant Medical Technologies is a pharmaceutical research and development company engaged in photodynamic therapy (PDT), a treatment modality based on drugs that respond to light. The drug and light procedures involve three components, the photoselective drugs, light producing devices and light delivery devices. The Company's products have been developed in-house and with outside collaborators and have been used in various clinical and preclinical investigations. Its most advanced drug, PHOTREX, generic name rostaporfin, has completed two Phase III clinical trials for the treatment of wet age-related macular degeneration (AMD). Miravant has branded its version of PDT technology with the trademark PhotoPoint.
Contact Information
- Headquarters
- 336 Bollay DriveSANTA BARBARA, CA, United States 93117
- Phone
- 805-685-9880
- Fax
- 805-685-7981
Executives
- Director
- Robert Sutcliffe
- Chief Financial Officer, Treasurer, Assistant Secretary
- John Philpott
- President, Director
- David Mai
- Director
- Nuno Brandolini
- Director
- Michael Khoury
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 37.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.41 |
Book Value | $-0.05 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
